Jaffetilchin Investment Partners, LLC Horizon Therapeutics Public LTD CO Transaction History

Jaffetilchin Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$96.34 - $112.38 $5,395 - $6,293	-56 Reduced 2.62%	2,084 $214,000
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $133,514 - $243,532	2,140 New	2,140 $243,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $203,519 - $258,602	-2,355 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$98.56 - $119.91 $788 - $959	8 Added 0.34%	2,355 $254,000
Q2 2021 Aug 09, 2021	SELL	$86.24 - $95.92 $157,215 - $174,862	-1,823 Reduced 43.72%	2,347 $220,000

Q1 2021 May 10, 2021	BUY	$71.83 - $95.48 $299,531 - $398,151	4,170 New	4,170 $384,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.